Skip to main content

Elisabet Miro Casas

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Elisabet Miro Casas

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Inhibición del intercambiador sodio/calcio mitocondrial, NCLX, como estrategia para reducir el daño por isquemia-reperfusión durante un infarto de miocardio

IP: Antonio Rodríguez Sinovas
Collaborators: Elisabet Miro Casas, Gino Freddy Sena Ganse
Funding agency: FUNDACIÓN ESPAÑOLA DE ARTERIOSCLEROSIS
Funding: 15000
Reference: FEA/RODRIGUEZ/2024
Duration: 01/01/2025 - 31/12/2027

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Elisabet Miro Casas, Marisol Ruiz Meana, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Fundación Eugenio Rodríguez Pascual
Funding: 25000
Reference: FERP/2024/RODRIGUEZ
Duration: 15/01/2025 - 14/01/2027

Role of amino acid metabolism reprogramming and calpain deregulation in fibroblasts activation and diffuse myocardial fibrosis in heart failure

IP: Javier Inserte Igual
Collaborators: José Antonio Barrabés Riu, David Aluja Gonzalez, Juan Garrido Oliver, Elisabet Miro Casas, Sara Delgado Tomás
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI23/00068
Duration: 01/01/2024 - 31/12/2026

Daño mitocondrial por estrés dicarbonílico como impulsor de la senescencia: papel de los senolíticos en la protección del corazón durante el envejecimiento.

IP: Marisol Ruiz Meana
Collaborators: Rafael Rodríguez Lecoq, David Aluja Gonzalez, Elisabet Miro Casas
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI22/00513
Duration: 01/01/2023 - 31/12/2025

Related news

The study, led by Vall d'Hebron, is the first in Spain to analyse the relationship between pregnancy complications and the risk of long-term cardiovascular diseases.

The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.

The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.

Related professionals

Montserrat García Portabella

Montserrat García Portabella

Reconstructive Surgery of the Locomotor System
Read more
Marta Ferri Peradalta

Marta Ferri Peradalta

P Management and Admin. Project manager
External Strategy Directorate
Read more
Marta Guerrero Parés

Marta Guerrero Parés

Transfusional Medicine
Read more
Ornella Giovanna Realini Fuentes

Ornella Giovanna Realini Fuentes

P Management and Admin. Project manager
Competitive Research Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.